FDA Releases Draft Guidance on Stability Testing for Drug Substances and Products

Summary

The Food and Drug Administration (FDA) has made available a draft guidance document outlining recommended stability studies for various types of drug applications, including new drug applications and biologics license applications, to support the approval of new pharmaceutical products.